Service des maladies infectieuses

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1807 publications

 
Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients.
Abela I.A., Scherrer A.U., Böni J., Yerly S., Klimkait T., Perreau M., Hirsch H.H., Furrer H., Calmy A., Schmid P. et al. Clinical infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5CD4824E50AC]
 
Link between heat shock protein 90 (Hsp90) and the mitochondrial respiratory chain in the caspofungin stress response of Aspergillus fumigatus.
Aruanno M., Bachmann D., Sanglard D., Lamoth F. Antimicrobial agents and chemotherapy. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_27BC0FBB5DCD]
 
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside.
Aruanno M., Glampedakis E., Lamoth F. Antimicrobial agents and chemotherapy. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5956AF923F85]
 
Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.
Asner S.A., Agyeman PKA, Gradoux E., Posfay-Barbe K.M., Heininger U., Giannoni E., Crisinel P.A., Stocker M., Bernhard-Stirnemann S., Niederer-Loher A. et al. Clinical infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_85BDE958775C]
 
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.
Barcelo C., Aouri M., Courlet P., Guidi M., Braun D.L., Günthard H.F., Piso R.J., Cavassini M., Buclin T., Decosterd L.A. et al. The Journal of antimicrobial chemotherapy. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_525CE7DE74FD]
 
Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
Blaser N., Bertisch B., Kouyos R.D., Calmy A., Bucher H.C., Cavassini M., Estill J., Keiser O., Egger M., Swiss HIV Cohort Study AIDS (London, England). Peer-reviewed.
[DOI] [Pmid] [serval:BIB_F647BA53F368]
 
Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection.
Carlisle L.A., Turk T., Kusejko K., Metzner K.J., Leemann C., Schenkel C., Bachmann N., Posada S., Beerenwinkel N., Böni J. et al. The Journal of infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_19B3C834E3FA]
 
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence.
Courlet P., Decosterd L.A., Brown J.A., Alves Saldanha S., Marzolini C., Cavassini M., Stoeckle M., Csajka C., Labhardt N.D., Calmy A. The Journal of antimicrobial chemotherapy. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5082024839D9]
 
Escitalopram population pharmacokinetics in people living with HIV and in the psychiatric population: drug-drug interactions and probability of target attainment.
Courlet P., Guidi M., Glatard A., Alves Saldanha S., Cavassini M., Buclin T., Marzolini C., Eap C.B., Decosterd L.A., Csajka C. et al. British journal of clinical pharmacology. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_F5C6318349C9]
 
Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate.
Dietrich L.G., Barceló C., Thorball C.W., Ryom L., Burkhalter F., Hasse B., Furrer H., Weisser M., Steffen A., Bernasconi E. et al. Clinical infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_CEFAD592E5CD]
 
Why do sub-Saharan Africans present late for HIV care in Switzerland?
Hachfeld A., Darling K., Calmy A., Ledergerber B., Weber R., Battegay M., Wissel K., Di Benedetto C., Fux C.A., Tarr P.E. et al. HIV medicine. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_30340E1FC965]
 
Reply to Mullish et al. "Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice?"
Huttner B.D., Galperine T., Kapel N., Harbarth S. Clinical microbiology and infection. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_D47D9E317652]
 
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F. et al. The Journal of infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_3FA288C9277D]
 
Safety and efficacy of C-reactive protein-guided antibiotic use to treat acute respiratory infections in Tanzanian children: a planned subgroup analysis of a randomized, controlled non-inferiority trial evaluating a novel electronic clinical decision algorithm (ePOCT).
Keitel K., Samaka J., Masimba J., Temba H., Said Z., Kagoro F., Mlaganile T., Sangu W., Genton B., D'Acremont V. Clinical infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5058473DDF07]
 
A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, non-communicable and opportunistic diseases.
Kusejko K., Bachmann N., Chaudron S.E., Nguyen H., Braun D.L., Hampel B., Battegay M., Bernasconi E., Calmy A., Cavassini M. et al. The Journal of infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_BB6E66056535]
 
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Manuel O., Estabrook M., American Society of Transplantation Infectious Diseases Community of Practice Clinical transplantation pp. e13511. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_917F5AC64A89]
 
HIV transmission chains exhibit greater HLA-B homogeneity than randomly expected.
Nguyen H., Thorball C.W., Fellay J., Böni J., Yerly S., Perreau M., Klimkait T., Kusjeko K., Bachmann N., Chaudron S.E. et al. Journal of acquired immune deficiency syndromes. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_6E0F5A3E41D4]
 
Understanding and Enhancing Sepsis Survivorship: Priorities for Research and Practice.
Prescott H.C., Iwashyna T.J., Blackwood B., Calandra T., Chlan L.L., Choong K., Connolly B., Dark P., Ferrucci L., Finfer S. et al. American journal of respiratory and critical care medicine. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_7E5D3936FBD5]
 
Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era.
Salazar-Vizcaya L., Kouyos R.D., Metzner K.J., Caraballo Cortes K., Böni J., Shah C., Fehr J., Braun D.L., Bernasconi E., Mbunkah H.A. et al. The Journal of infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_DB771CDF18E0]
 
Clusters of sexual behaviour in HIV-positive men who have sex with men reveal highly dissimilar time trends.
Salazar-Vizcaya L., Kusejko K., Schmidt A.J., Carrillo-Montoya G., Nicca D., Wandeler G., Braun D.L., Fehr J., Darling KEA, Bernasconi E. et al. Clinical infectious diseases. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5BE78DDA1CF4]
 
Phylogenomics reveal that Mycobacterium kansasii subtypes are species-level lineages. Description of Mycobacterium pseudokansasii sp. nov., Mycobacterium innocens sp. nov. and Mycobacterium attenuatum sp. nov.
Tagini F., Aeby S., Bertelli C., Droz S., Casanova C., Prod'hom G., Jaton K., Greub G. International journal of systematic and evolutionary microbiology. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_9F91FAF18341]
 
The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.
Young J., Scherrer A.U., Calmy A., Tarr P.E., Bernasconi E., Cavassini M., Hachfeld A., Vernazza P., Günthard H.F., Bucher H.C. et al. Antiviral therapy. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_EE3F2AF63928]
 
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
Cornely O.A., Vehreschild MJGT, Adomakoh N., Georgopali A., Karas A., Kazeem G., Guery B., 2019/06. European journal of clinical microbiology & infectious diseases, 38 (6) pp. 1187-1194. Peer-reviewed.
 
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.
Albasanz-Puig A., Gudiol C., Parody R., Tebe C., Akova M., Araos R., Bote A., Brunel A.S., Calik S., Drgona L. et al., 2019/05/24. BMJ open, 9 (5) pp. e025744. Peer-reviewed.
 
Clinical relevance of preservation-fluid contamination in solid-organ transplantation: a call for mounting the evidence.
Yahav D., Manuel O., 2019/05. Clinical microbiology and infection, 25 (5) pp. 536-537. Peer-reviewed.
 
Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
Cornu M., Sendid B., Mery A., François N., Malgorzata M., Letscher-Bru V., De Carolis E., Damonti L., Titecat M., Bochud P.Y. et al., 2019/05. Journal of clinical microbiology, 57 (5). Peer-reviewed.
Diagnostic Performance of Conventional and Ultrasensitive Rapid Diagnostic Tests for Malaria in Febrile Outpatients in Tanzania.
Hofmann N.E., Antunes Moniz C., Holzschuh A., Keitel K., Boillat-Blanco N., Kagoro F., Samaka J., Mbarack Z., Ding X.C., González I.J. et al., 2019/04/16. The Journal of infectious diseases, 219 (9) pp. 1490-1498. Peer-reviewed.
 
Infectiologie sur mesure - 1.Immunogénétique des maladies infectieuses : premiers pas [Customised infectiology - Immunogenetics]
Neofytos D., Bibert S., Bochud P.Y., 2019/04/10. Revue medicale suisse, 15 (646) pp. 766-770. Peer-reviewed.
 
Infectiologie sur mesure - 2. Phagothérapie : de la théorie à l’évidence clinique [Customised infectiology - Phage therapy: from theory to clinical evidence]
Desgranges F., Bochud P.Y., Resch G., 2019/04/10. Revue medicale suisse, 15 (646) pp. 771-775. Peer-reviewed.
 
Infectiologie sur mesure - 3. Transplantation de microbiote fécal : l’exemple du traitement de Clostridioides difficile [Customised infectiology - Fecal microbiota transplantation : following the Clostridioides difficile pathway]
Galperine T.K., Guery B., 2019/04/10. Revue medicale suisse, 15 (646) pp. 776-779. Peer-reviewed.
 
La personnalisation : une approche ancrée dans les gènes de l’infectiologie []
Bochud P.Y., Kaiser L., Calandra T., 2019/04/10. Revue medicale suisse, 15 (646) pp. 763-764. Peer-reviewed.
Cardiac Implantable Electronic Device-Related Infection Due to Granulicatella adiacens.
Sendi P., Wustmann K., Büchi A.E., Noti F., Klaeser B., Sonderegger B., Auf der Maur C., Mercier T., Schwerzmann M., Ruppen C., 2019/04. Open forum infectious diseases, 6 (4) pp. ofz130. Peer-reviewed.
 
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Bassetti M., Scudeller L., Giacobbe D.R., Lamoth F., Righi E., Zuccaro V., Grecchi C., Rebuffi C., Akova M., Alastruey-Izquierdo A. et al., 2019/04. Mycoses, 62 (4) pp. 310-319. Peer-reviewed.
 
Diagnostic approach to encephalitis and meningoencephalitis in adult returning travellers.
Kenfak A., Eperon G., Schibler M., Lamoth F., Vargas M.I., Stahl J.P., 2019/04. Clinical microbiology and infection, 25 (4) pp. 415-421. Peer-reviewed.
 
Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis.
Fernández-Ruiz M., Giménez E., Lora D., Aguado J.M., Pascual M., Manuel O., 2019/04. American journal of transplantation, 19 (4) pp. 1072-1085. Peer-reviewed.
 
Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009-2017) in a university Greek hospital.
Papadimitriou-Olivgeris M., Spiliopoulou A., Kolonitsiou F., Bartzavali C., Lambropoulou A., Xaplanteri P., Anastassiou E.D., Marangos M., Spiliopoulou I., Christofidou M., 2019/04. Infection, 47 (2) pp. 209-216. Peer-reviewed.
 
Molecular diagnosis and enrichment culture identified a septic pseudoarthrosis due to an infection with Erysipelatoclostridium ramosum.
Zakham F., Pillonel T., Brunel A.S., Zambelli P.Y., Greub G., Croxatto A., Bertelli C., 2019/04. International journal of infectious diseases, 81 pp. 167-169. Peer-reviewed.
 
Clostridium difficile infection trials: what is the primary endpoint?
Guery B., 2019/03. The Lancet. Infectious diseases, 19 (3) pp. 219-220. Peer-reviewed.
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
Gras L., May M., Ryder L.P., Trickey A., Helleberg M., Obel N., Thiebaut R., Guest J., Gill J., Crane H. et al., 2019/03/01. Journal of acquired immune deficiency syndromes, 80 (3) pp. 292-300. Peer-reviewed.
 
Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study.
Leon-Reyes S., Schäfer J., Früh M., Schwenkglenks M., Reich O., Schmidlin K., Staehelin C., Battegay M., Cavassini M., Hasse B. et al., 2019/02/15. Clinical infectious diseases, 68 (5) pp. 827-833. Peer-reviewed.
 
Assessment of voluntary HIV screening for asylum seekers in two Swiss cantons.
Cochand L., Masserey E., Bodenmann P., Troillet N., 2019/02/11. Swiss medical weekly, 149 pp. w20020. Peer-reviewed.
 
Isavuconazole brain penetration in cerebral aspergillosis.
Lamoth F., Mercier T., André P., Pagani J.L., Pantet O., Maduri R., Guery B., Decosterd L.A., 2019/02/11. The Journal of antimicrobial chemotherapy pp. 73-97. Peer-reviewed.
 
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
Opota O., Zakham F., Mazza-Stalder J., Nicod L., Greub G., Jaton K., 2019/02. Journal of clinical microbiology, 57 (2). Peer-reviewed.
 
Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Mueller N.J., Binet I., Van Delden C., Steiger J., Mohacsi P. et al., 2019/02. The pharmacogenomics journal, 19 (1) pp. 53-64. Peer-reviewed.
Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018
Rodríguez-Sánchez Belén, Cercenado Emilia, Coste Alix T., Greub Gilbert, 2019/01/24. Eurosurveillance, 24 (4).
 
Ebola Vaccines : ready to use for humanitarian health workers?
Genton B., 2019/01/18. Journal of travel medicine. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_F5F106F2CB5E]
 
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Steiner-Monard V., Kamaka K., Karoui O., Roethlisberger S., Audran R., Daubenberger C., Fayet-Mello A., Erdmann-Voisin A., Felger I., Geiger K. et al., 2019/01/18. Clinical infectious diseases, 68 (3) pp. 466-474. Peer-reviewed.
 
Nouveautés dans le dépistage, la prévention et la prise en charge du VIH en 2018 [Diagnosis, prevention and treatment of HIV : what's new in 2018 ?]
D'Incau S., Viala B., Ciuffi A., Cavassini M., Calmy A., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 107-112. Peer-reviewed.
Detection of dicistroviruses RNA in blood of febrile Tanzanian children.
Cordey S., Laubscher F., Hartley M.A., Junier T., Pérez-Rodriguez F.J., Keitel K., Vieille G., Samaka J., Mlaganile T., Kagoro F. et al., 2019. Emerging microbes & infections, 8 (1) pp. 613-623. Peer-reviewed.
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver I.T., Théroude C., Roger T., 2019. Frontiers in immunology, 10 p. 327. Peer-reviewed.
Retrospective study on the usefulness of pulse oximetry for the identification of young children with severe illnesses and severe pneumonia in a rural outpatient clinic of Papua New Guinea.
Blanc J., Locatelli I., Rarau P., Mueller I., Genton B., Boillat-Blanco N., Gehri M., Senn N., 2019. PloS one, 14 (4) pp. e0213937. Peer-reviewed.
 
Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C., Manuel O. et al., 2019/01. Transplant international, 32 (1) pp. 49-58. Peer-reviewed.
Mass drug administration for malaria elimination: do we understand the settings well enough?
Hetzel M.W., Genton B., 2018/12/19. BMC medicine, 16 (1) p. 239. Peer-reviewed.
Dengue fever in Dar es Salaam, Tanzania: clinical features and outcome in populations of black and non-black racial category.
Boillat-Blanco N., Klaassen B., Mbarack Z., Samaka J., Mlaganile T., Masimba J., Franco Narvaez L., Mamin A., Genton B., Kaiser L. et al., 2018/12/12. BMC infectious diseases, 18 (1) p. 644. Peer-reviewed.
Multidisciplinary Collaboration between a Community Pharmacy and a Travel Clinic in a Swiss University Primary Care and Public Health Centre.
Berger J., Barbalat M.J., Pavón Clément V., Genton B., Bugnon O., 2018/12/05. Pharmacy, 6 (4) p. 126. Peer-reviewed.
 
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
Burger R., Guidi M., Calpini V., Lamoth F., Decosterd L., Robatel C., Buclin T., Csajka C., Marchetti O., 2018/12/01. The Journal of antimicrobial chemotherapy, 73 (12) pp. 3413-3422. Peer-reviewed.
 
Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
Glampedakis E., Coste A.T., Aruanno M., Bachmann D., Delarze E., Erard V., Lamoth F., 2018/12. Antimicrobial agents and chemotherapy, 62 (12). Peer-reviewed.
 
Non-targeted HIV testing in the emergency department: not just how but where.
Tan R., Hugli O., Cavassini M., Darling K., 2018/12. Expert review of anti-infective therapy, 16 (12) pp. 893-905. Peer-reviewed.
 
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D., Hirzel C., Boely E., Lecompte T., Khanna N., Mueller N.J., Boggian K., Cusini A., Manuel O., van Delden C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12984. Peer-reviewed.
 
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals.
Conconi A., Zucca E., Margiotta-Casaluci G., Darling K., Hasse B., Battegay M., Staehelin C., Novak U., Schmid P., Scherrer A. et al., 2018/12. Hematological oncology, 36 (5) pp. 757-764. Peer-reviewed.
 
Rational approach in the management of Pseudomonas aeruginosa infections.
Bassetti M., Vena A., Russo A., Croxatto A., Calandra T., Guery B., 2018/12. Current opinion in infectious diseases, 31 (6) pp. 578-586. Peer-reviewed.
 
The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size.
Fuchs K., Cardona Gloria Y., Wolz O.O., Herster F., Sharma L., Dillen C.A., Täumer C., Dickhöfer S., Bittner Z., Dang T.M. et al., 2018/12. EMBO reports, 19 (12). Peer-reviewed.
 
Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
Rello J., van Engelen TSR, Alp E., Calandra T., Cattoir V., Kern W.V., Netea M.G., Nseir S., Opal S.M., van de Veerdonk F.L. et al., 2018/12. Clinical microbiology and infection, 24 (12) pp. 1264-1272. Peer-reviewed.
 
Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.
Bibert S., Wójtowicz A., Taffé P., Tarr P.E., Bernasconi E., Furrer H., Günthard H.F., Hoffmann M., Kaiser L., Osthoff M. et al., 2018/11/28. AIDS, 32 (18) pp. 2759-2765. Peer-reviewed.
 
Biomarqueurs systèmiques pour les infections respiratoires [Systemic biomarkers in respiratory tract infections]
Balmpouzis Z., Diamanti E., Kritikos A., Guery B., Nicod L.P., 2018/11/14. Revue medicale suisse, 14 (627) pp. 2074-2078. Peer-reviewed.
 
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A., Neofytos D., Khanna N., Schreiber P.W., Boggian K., Bille J., Schrenzel J., Mühlethaler K., Zbinden R., Bruderer T. et al., 2018/11. Clinical microbiology and infection, 24 (11) pp. 1214.e1-1214.e4. Peer-reviewed.
 
Corrigendum to "Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years" [J Hepatol 49 (2008) 72-77].
Torgerson P.R., Schweiger A., Deplazes P., Pohar M., Reichen J., Ammann R.W., Tarr P.E., Halkic N., Müllhaupt B., 2018/11..
 
Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.
Brunel A.S., Wójtowicz A., Lamoth F., Spertini O., Neofytos D., Calandra T., Marchetti O., Bochud P.Y., 2018/11. Haematologica, 103 (11) pp. e527-e530. Peer-reviewed.
 
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.
Kusejko K., Marzel A., Hampel B., Bachmann N., Nguyen H., Fehr J., Braun D.L., Battegay M., Bernasconi E., Calmy A. et al., 2018/11. HIV medicine, 19 (10) pp. 688-697. Peer-reviewed.
CD32<sup>+</sup> and PD-1<sup>+</sup> Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
Noto A., Procopio F.A., Banga R., Suffiotti M., Corpataux J.M., Cavassini M., Riva A., Fenwick C., Gottardo R., Perreau M. et al., 2018/10/15. Journal of virology, 92 (20). Peer-reviewed.
 
Antibiotics for Sepsis-Finding the Equilibrium.
Klompas M., Calandra T., Singer M., 2018/10/09. JAMA, 320 (14) pp. 1433-1434. Peer-reviewed.
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T., Martenet S., Mamin R., Du Pasquier R.A., Peters S., Perreau M., Muller O., Hugli O., Cavassini M., Darling KEA, 2018/10/03. BMJ open, 8 (10) pp. e021203. Peer-reviewed.
 
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
Aguilar C.A., Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Ussetti P., Chin-Hong P.V., Sole A., Holmes-Liew C., Billaud E.M. et al., 2018/10. The Journal of heart and lung transplantation, 37 (10) pp. 1226-1234. Peer-reviewed.
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
 
Let's add invasive aspergillosis to the list of influenza complications.
Lamoth F., Calandra T., 2018/10. The Lancet. Respiratory medicine, 6 (10) pp. 733-735. Peer-reviewed.
 
Native aortic valve endocarditis due to Pseudomonas stutzeri in a 91-year-old woman.
Héquette-Ruz R., Charpentier A., Delabriere I., Loiez C., Guery B., Puisieux F., Beuscart J.B., 2018/10. Medecine et maladies infectieuses, 48 (7) pp. 492-494. Peer-reviewed.
 
Neonatal Sepsis of Early Onset, and Hospital-Acquired and Community-Acquired Late Onset: A Prospective Population-Based Cohort Study.
Giannoni E., Agyeman PKA, Stocker M., Posfay-Barbe K.M., Heininger U., Spycher B.D., Bernhard-Stirnemann S., Niederer-Loher A., Kahlert C.R., Donas A. et al., 2018/10. The Journal of pediatrics, 201 pp. 106-114.e4. Peer-reviewed.
Erratum for Williams et al., “Investigation of the Plasma Virome from Cases of Unexplained Febrile Illness in Tanzania from 2013 to 2014: a Comparative Analysis between Unbiased and VirCapSeq-VERT High-Throughput Sequencing Approaches”
Williams Simon H., Cordey Samuel, Bhuva Nishit, Laubscher Florian, Hartley Mary-Anne, Boillat-Blanco Noémie, Mbarack Zainab, Samaka Josephine, Mlaganile Tarsis, Jain Komal et al., 2018/09/19. mSphere, 3 (5) pp. e00477-18.
 
Content analysis of antiretroviral adherence enhancing interview reports.
Kamal S., Nulty P., Bugnon O., Cavassini M., Schneider M.P., 2018/09. Patient education and counseling, 101 (9) pp. 1676-1682. Peer-reviewed.
 
Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe.
Coussement J., Maggiore U., Manuel O., Scemla A., López-Medrano F., Nagler E.V., Aguado J.M., Abramowicz D., European Renal Association-European Dialysis Transplant Association, (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in et al., 2018/09/01. Nephrology, dialysis, transplantation, 33 (9) pp. 1661-1668. Peer-reviewed.
 
Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study.
Voumard R., Gardiol C., André P., Arensdorff L., Cochet C., Boillat-Blanco N., Decosterd L., Buclin T., de Vallière S., 2018/09/01. The Journal of antimicrobial chemotherapy, 73 (9) pp. 2540-2545. Peer-reviewed.
 
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.
Kouyos R.D., Rusert P., Kadelka C., Huber M., Marzel A., Ebner H., Schanz M., Liechti T., Friedrich N., Braun D.L. et al., 2018/09. Nature, 561 (7723) pp. 406-410. Peer-reviewed.
 
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia.
Giulieri S.G., Baines S.L., Guerillot R., Seemann T., Gonçalves da Silva A., Schultz M., Massey R.C., Holmes N.E., Stinear T.P., Howden B.P., 2018/08/23. Genome medicine, 10 (1) p. 65. Peer-reviewed.
Investigation of the Plasma Virome from Cases of Unexplained Febrile Illness in Tanzania from 2013 to 2014: a Comparative Analysis between Unbiased and VirCapSeq-VERT High-Throughput Sequencing Approaches.
Williams S.H., Cordey S., Bhuva N., Laubscher F., Hartley M.A., Boillat-Blanco N., Mbarack Z., Samaka J., Mlaganile T., Jain K. et al., 2018/08/22. mSphere, 3 (4) pp. e00311-18. Peer-reviewed.
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
 
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D., Chatzis O., Nasioudis D., Boely Janke E., Doco Lecompte T., Garzoni C., Berger C., Cussini A., Boggian K., Khanna N. et al., 2018/08. Transplant infectious disease, 20 (4) pp. e12898. Peer-reviewed.
 
Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
Robert-Gangneux F., Meroni V., Dupont D., Botterel F., Garcia JMA, Brenier-Pinchart M.P., Accoceberry I., Akan H., Abbate I., Boggian K. et al., 2018/08. Emerging infectious diseases, 24 (8) pp. 1497-1504. Peer-reviewed.
Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950-2017: protocol for a systematic review.
Nyazika T.K., Tatuene J.K., Kenfak-Foguena A., Verweij P.E., Meis J.F., Robertson V.J., Hagen F., 2018/07/30. BMJ open, 8 (7) pp. e020654. Peer-reviewed.
 
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
Cusini A., Béguelin C., Stampf S., Boggian K., Garzoni C., Koller M., Manuel O., Meylan P., Mueller N.J., Hirsch H.H. et al., 2018/07. American journal of transplantation, 18 (7) pp. 1745-1754. Peer-reviewed.
HIV testing history and access to treatment among migrants living with HIV in Europe.
Fakoya I., Álvarez-Del Arco D., Monge S., Copas A.J., Gennotte A.F., Volny-Anne A., Wengenroth C., Touloumi G., Prins M., Barros H. et al., 2018/07. Journal of the International AIDS Society, 21 Suppl 4 pp. e25123. Peer-reviewed.
Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Salazar-Vizcaya L., Wandeler G., Fehr J., Braun D., Cavassini M., Stoeckle M., Bernasconi E., Hoffmann M., Rougemont M., Béguelin C. et al., 2018/07. Open forum infectious diseases, 5 (7) pp. ofy154. Peer-reviewed.
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study.
Kusejko K., Kadelka C., Marzel A., Battegay M., Bernasconi E., Calmy A., Cavassini M., Hoffmann M., Böni J., Yerly S. et al., 2018/07. Virus evolution, 4 (2) pp. vey024. Peer-reviewed.
 
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
Aebi-Popp K., Wandeler G., Salazar-Vizcaya L., Metzner K., Stöckle M., Cavassini M., Hoffmann M., Lüthi A., Suter F., Bernasconi E. et al., 2018/07. HIV medicine, 19 (6) pp. 420-425. Peer-reviewed.
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.
Hughes R.A., May M.T., Tilling K., Taylor N., Wittkop L., Reiss P., Gill J., Schommers P., Costagliola D., Guest J.L. et al., 2018/06/19. AIDS, 32 (10) pp. 1361-1367. Peer-reviewed.
Missed opportunities for HIV testing among patients newly presenting for HIV care at a Swiss university hospital: a retrospective analysis.
Lhopitallier L., Moulin E., Hugli O., Cavassini M., Darling KEA, 2018/06/12. BMJ open, 8 (6) pp. e019806. Peer-reviewed.
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.
Kadelka C., Liechti T., Ebner H., Schanz M., Rusert P., Friedrich N., Stiegeler E., Braun D.L., Huber M., Scherrer A.U. et al., 2018/06/04. The Journal of experimental medicine, 215 (6) pp. 1589-1608. Peer-reviewed.
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G., Michielin O., Cervera C., Ribi C., Aguado J.M., Fernández-Ruiz M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S95-S107. Peer-reviewed.
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).
Fernández-Ruiz M., Meije Y., Manuel O., Akan H., Carratalà J., Aguado J.M., Delaloye J., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S2-S9. Peer-reviewed.
Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4<sup>+</sup> T cell responses in Tanzanian adults with latent or active tuberculosis.
Boillat-Blanco N., Tumbo A.N., Perreau M., Amelio P., Ramaiya K.L., Mganga M., Schindler C., Gagneux S., Reither K., Probst-Hensch N. et al., 2018/06. Immunity, inflammation and disease, 6 (2) pp. 345-353. Peer-reviewed.
 
Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.
Averbuch D., Orasch C., Mikulska M., Livermore D.M., Viscoli C., Gyssens I.C., Kern W.V., Klyasova G., Marchetti O., Engelhard D. et al., 2018/06. Clinical microbiology and infection, 24 (6) pp. 662-663. Peer-reviewed.
 
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Couchepin J., Brunel A.S., Jaton K., Meylan P., Bochud P.Y., Lamoth F., 2018/06. Mycoses, 61 (6) pp. 350-354. Peer-reviewed.
 
LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation.
Gallay J., Prod'hom S., Mercier T., Bardinet C., Spaggiari D., Pothin E., Buclin T., Genton B., Decosterd L.A., 2018/05/30. Journal of pharmaceutical and biomedical analysis, 154 pp. 263-277. Peer-reviewed.
 
No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients.
Strouvelle V.P., Braun D.L., Vongrad V., Scherrer A.U., Kok Y.L., Kouyos R.D., Stöckle M., Rauch A., Darling K., Hoffmann M. et al., 2018/05/25. The Journal of infectious diseases, 217 (12) pp. 1883-1888. Peer-reviewed.
Appropriateness of malaria diagnosis and treatment for fever episodes according to patient history and anti-malarial blood measurement: a cross-sectional survey from Tanzania.
Gallay J., Mosha D., Lutahakana E., Mazuguni F., Zuakulu M., Decosterd L.A., Genton B., Pothin E., 2018/05/21. Malaria journal, 17 (1) p. 209. Peer-reviewed.
 
Detection of Chlamydiaceae and Chlamydia-like organisms on the ocular surface of children and adults from a trachoma-endemic region.
Ghasemian E., Inic-Kanada A., Collingro A., Tagini F., Stein E., Alchalabi H., Schuerer N., Keše D., Babiker B.E., Borel N. et al., 2018/05/09. Scientific reports, 8 (1) p. 7432. Peer-reviewed.
 
Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
Hughes R.A., May M.T., Tilling K., Taylor N., Wittkop L., Reiss P., Gill J., Schommers P., Costagliola D., Guest J.L. et al., 2018/05/03. AIDS pp. 1361-1367. Peer-reviewed.
 
Consultation prévoyage : plus précise, plus complexe
Chappuis F., Genton B., 2018/05/02. Revue medicale suisse, 14 (605) pp. 915-916. Peer-reviewed.
 
Le voyageur face au VIH et le voyageur vivant avec le VIH [Travelers' exposure to HIV and HIV-infected travelers]
Boillat-Blanco N., Cavassini M., Genton B., 2018/05/02. Revue medicale suisse, 14 (605) pp. 918-921. Peer-reviewed.
 
Travel Apps : applications et sites web en médecine des voyagess [Travel Apps: applications and websites of travel medicine]
Genton B., D'Acremont V., 2018/05/02. Revue medicale suisse, 14 (605) pp. 938-940. Peer-reviewed.
 
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann A.J., Aguado J.M., Arikan-Akdagli S., Denning D.W., Groll A.H., Lagrou K., Lass-Flörl C., Lewis R.E., Munoz P., Verweij P.E. et al., 2018/05. Clinical microbiology and infection, 24 Suppl 1 pp. e1-e38. Peer-reviewed.
 
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.
Orasch C., Mertz D., Garbino J., van Delden C., Emonet S., Schrenzel J., Zimmerli S., Damonti L., Mühlethaler K., Imhof A. et al., 2018/05. The Journal of infection, 76 (5) pp. 489-495. Peer-reviewed.
 
Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study.
Aebi-Popp K., Mercanti V., Voide C., Nemeth J., Cusini A., Jakopp B., Nicca D., Rasi M., Bruno A., Calmy A. et al., 2018/05. HIV medicine, 19 (5) pp. 339-346. Peer-reviewed.
The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis.
Marzel A., Kusejko K., Weber R., Bruggmann P., Rauch A., Roth J.A., Bernasconi E., Calmy A., Cavassini M., Hoffmann M. et al., 2018/05. Open forum infectious diseases, 5 (5) pp. ofy078. Peer-reviewed.
 
Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Activation Balance Astrocyte Polarization into a Proinflammatory Phenotype.
Rosciszewski G., Cadena V., Murta V., Lukin J., Villarreal A., Roger T., Ramos A.J., 2018/05. Molecular neurobiology, 55 (5) pp. 3875-3888. Peer-reviewed.
What is the true clinical relevance of Simkania negevensis and other emerging Chlamydiales members?
Vouga M., Kebbi-Beghdadi C., Liénard J., Baskin L., Baud D., Greub G., 2018/05. New microbes and new infections, 23 pp. 1-5. Peer-reviewed.
Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity in Latent and Reactivated HIV-Infected Cells.
Golumbeanu M., Cristinelli S., Rato S., Munoz M., Cavassini M., Beerenwinkel N., Ciuffi A., 2018/04/24. Cell reports, 23 (4) pp. 942-950. Peer-reviewed.
 
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.
Yu K., Davidson C.L., Wójtowicz A., Lisboa L., Wang T., Airo A.M., Villard J., Buratto J., Sandalova T., Achour A. et al., 2018/04/02. The Journal of clinical investigation, 128 (4) pp. 1523-1537. Peer-reviewed.
Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix<sup>®</sup> RT-PCR.
Wagner K., Springer B., Imkamp F., Opota O., Greub G., Keller P.M., 2018/04. International journal of medical microbiology, 308 (3) pp. 317-323. Peer-reviewed.
 
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule.
Veit O., Domingo C., Niedrig M., Staehelin C., Sonderegger B., Héquet D., Stoeckle M., Calmy A., Schiffer V., Bernasconi E. et al., 2018/03/19. Clinical infectious diseases, 66 (7) pp. 1099-1108. Peer-reviewed.
 
Immune Monitoring for CMV in Transplantation.
Yong M.K., Lewin S.R., Manuel O., 2018/03/14. Current infectious disease reports, 20 (4) p. 4. Peer-reviewed.
Microbial metagenome of urinary tract infection.
Moustafa A., Li W., Singh H., Moncera K.J., Torralba M.G., Yu Y., Manuel O., Biggs W., Venter J.C., Nelson K.E. et al., 2018/03/12. Scientific reports, 8 (1) p. 4333. Peer-reviewed.
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.
Chatzis O., Darbre S., Pasquier J., Meylan P., Manuel O., Aubert J.D., Beck-Popovic M., Masouridi-Levrat S., Ansari M., Kaiser L. et al., 2018/03/06. BMC infectious diseases, 18 (1) p. 111. Peer-reviewed.
 
Are privacy-enhancing technologies for genomic data ready for the clinic? A survey of medical experts of the Swiss HIV Cohort Study.
Raisaro J.L., McLaren P.J., Fellay J., Cavassini M., Klersy C., Hubaux J.P., Swiss HIV Cohort Study, 2018/03. Journal of biomedical informatics, 79 pp. 1-6. Peer-reviewed.
 
Biphasic lung injury during Streptococcus pneumoniae infection in a murine model.
Prevotat A., Rouyer C., Gosset P., Kipnis E., Faure K., Guery B., 2018/03. Medecine et maladies infectieuses, 48 (2) pp. 103-113. Peer-reviewed.
 
Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Damonti L., Erard V., Garbino J., Schrenzel J., Zimmerli S., Mühlethaler K., Imhof A., Zbinden R., Fehr J., Boggian K. et al., 2018/03..
 
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Guery B., Menichetti F., Anttila V.J., Adomakoh N., Aguado J.M., Bisnauthsing K., Georgopali A., Goldenberg S.D., Karas A., Kazeem G. et al., 2018/03. The Lancet. Infectious diseases, 18 (3) pp. 296-307. Peer-reviewed.
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
Béguelin C., Suter A., Bernasconi E., Fehr J., Kovari H., Bucher H.C., Stoeckle M., Cavassini M., Rougemont M., Schmid P. et al., 2018/03. Liver international, 38 (3) pp. 424-431. Peer-reviewed.
 
Exploring ways to improve CDI outcomes.
Galpérine T., Guery B., French Group of Fecal Microbiota Transplantation (GFTF), 2018/02. Medecine et maladies infectieuses, 48 (1) pp. 10-17. Peer-reviewed.
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2018/02. Clinical microbiology and infection, 24 (2) pp. 192-198. Peer-reviewed.
 
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America.
Clemente W.T., Pierrotti L.C., Abdala E., Morris M.I., Azevedo L.S., López-Vélez R., Cuenca-Estrella M., Torre-Cisneros J., Petersen E., Camargo LFA et al., 2018/02. Transplantation, 102 (2) pp. 193-208. Peer-reviewed.
 
Temporal trends and epidemiology of Staphylococcus aureus surgical site infection in the Swiss surveillance network: a cohort study
Abbas M., Aghayev E., Troillet N., Eisenring M.-C., Kuster S.P., Widmer A.F., Harbarth S., Balmelli Carlo, Eisenring Marie-Christine, Harbarth Stephan et al., 2018/02. Journal of Hospital Infection, 98 (2) pp. 118-126.
 
Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord, 2018/02/01. Clinical infectious diseases, 66 (4) pp. 594-603. Peer-reviewed.
 
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
Stucchi RSB, Lopes M.H., Kumar D., Manuel O., 2018/02. Transplantation, 102 (2S Suppl 2) pp. S72-S80. Peer-reviewed.
 
The Candida auris Alert: Facts and Perspectives.
Lamoth F., Kontoyiannis D.P., 2018/01/30. The Journal of infectious diseases, 217 (4) pp. 516-520. Peer-reviewed.
 
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
Mocroft A., Laut K., Reiss P., Gatell J., Ormaasen V., Cavassini M., Hadziosmanovic V., Mansinho K., Pradier C., Vasylyev M. et al., 2018/01/14. AIDS, 32 (2) pp. 205-215. Peer-reviewed.
 
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTI.
Amyai N., Darling K., D'Acremont V., Castro E., Ebert S., Diserens M.M., Perdrix J., Fossati A.H., Bodenmann P., Cavassini M., 2018/01. International journal of STD & AIDS, 29 (1) pp. 51-56. Peer-reviewed.
 
Blood CXCR3 (+) CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.
Banga R., Procopio F.A., Ruggiero A., Noto A., Ohmiti K., Cavassini M., Corpataux J.M., Paxton W.A., Pollakis G., Perreau M., 2018. Frontiers in immunology, 9 p. 144. Peer-reviewed.
Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., Bonani M., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C. et al., 2018. PloS one, 13 (1) pp. e0191167. Peer-reviewed.
 
Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F., Lockhart S.R., Berkow E.L., Calandra T., 2018/01/01. The Journal of antimicrobial chemotherapy, 73 (suppl_1) pp. i4-i13. Peer-reviewed.
 
Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infection.
Kobas M., Bickle Graz M., Truttmann A.C., Giannoni E., Meylan P., Asner S.A., 2018. Swiss medical weekly, 148 pp. w14627. Peer-reviewed.
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity.
Bertels F., Marzel A., Leventhal G., Mitov V., Fellay J., Günthard H.F., Böni J., Yerly S., Klimkait T., Aubert V. et al., 2018/01/01. Molecular biology and evolution, 35 (1) pp. 27-37. Peer-reviewed.
Distinct Genomic Features Characterize Two Clades of <i>Corynebacterium diphtheriae</i>: Proposal of <i>Corynebacterium diphtheriae</i> Subsp. <i>diphtheriae</i> Subsp. nov. and <i>Corynebacterium diphtheriae</i> Subsp. <i>lausannense</i> Subsp. nov.
Tagini F., Pillonel T., Croxatto A., Bertelli C., Koutsokera A., Lovis A., Greub G., 2018. Frontiers in microbiology, 9 p. 1743. Peer-reviewed.
 
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M., Averbuch D., Tissot F., Cordonnier C., Akova M., Calandra T., Ceppi M., Bruzzi P., Viscoli C., European Conference on Infections in Leukemia (ECIL), 2018/01. The Journal of infection, 76 (1) pp. 20-37. Peer-reviewed.
 
HIV and Aging - Perhaps Not as Dramatic as We Feared?
Engel T., Raffenberg M., Marzolini C., Cavassini M., Kovari H., Hasse B., Tarr P.E., 2018. Gerontology, 64 (5) pp. 446-456. Peer-reviewed.
 
HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.
Kamal S., Bugnon O., Cavassini M., Schneider M.P., 2018/01. HIV medicine, 19 (1) pp. 49-58. Peer-reviewed.
How to manage <i>Pseudomonas aeruginosa</i> infections.
Bassetti M., Vena A., Croxatto A., Righi E., Guery B., 2018. Drugs in context, 7 p. 212527. Peer-reviewed.
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.
Pettit A.C., Giganti M.J., Ingle S.M., May M.T., Shepherd B.E., Gill M.J., Fätkenheuer G., Abgrall S., Saag M.S., Del Amo J. et al., 2018/01. Journal of the International AIDS Society, 21 (1) pp. NA. Peer-reviewed.
 
IRF5 Is a Key Regulator of Macrophage Response to Lipopolysaccharide in Newborns.
Schneider A., Weier M., Herderschee J., Perreau M., Calandra T., Roger T., Giannoni E., 2018. Frontiers in immunology, 9 p. 1597. Peer-reviewed.
Molecular characterization of Treponema pallidum subsp. pallidum in Switzerland and France with a new multilocus sequence typing scheme.
Grillová L., Bawa T., Mikalová L., Gayet-Ageron A., Nieselt K., Strouhal M., Sednaoui P., Ferry T., Cavassini M., Lautenschlager S. et al., 2018. PloS one, 13 (7) pp. e0200773. Peer-reviewed.
 
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.
Salazar-Vizcaya L., Kouyos R.D., Fehr J., Braun D., Estill J., Bernasconi E., Delaloye J., Stöckle M., Schmid P., Rougemont M. et al., 2018/01. Journal of viral hepatitis, 25 (1) pp. 10-18. Peer-reviewed.
 
Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania.
Gallay J., Pothin E., Mosha D., Lutahakana E., Mazuguni F., Zuakulu M., Decosterd L.A., Genton B., 2018. PloS one, 13 (9) pp. e0202745. Peer-reviewed.
Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam, Tanzania.
Boillat-Blanco N., Mbarack Z., Samaka J., Mlaganile T., Mamin A., Genton B., Kaiser L., Calandra T., D'Acremont V., 2018. PloS one, 13 (6) pp. e0197982. Peer-reviewed.
Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial Infections.
Heinonen T., Ciarlo E., Théroude C., Pelekanou A., Herderschee J., Le Roy D., Roger T., 2018. Frontiers in immunology, 9 p. 2675. Peer-reviewed.
Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.
Gillet C., Darling KEA, Senn N., Cavassini M., Hugli O., 2018. PloS one, 13 (3) pp. e0190767. Peer-reviewed.
 
Telemedicine for health issues while abroad: interest and willingness to pay among travellers prior to departure.
Rochat L., Genton B., 2018/01/01. Journal of travel medicine, 25 (1) pp. NA. Peer-reviewed.
Time-to-Positivity of Blood Cultures in Children With Sepsis.
Dierig A., Berger C., Agyeman PKA, Bernhard-Stirnemann S., Giannoni E., Stocker M., Posfay-Barbe K.M., Niederer-Loher A., Kahlert C.R., Donas A. et al., 2018. Frontiers in pediatrics, 6 p. 222. Peer-reviewed.
 
Travailleuses du sexe et accès aux soins
Gloor E., Mestre-Augustoni G., Ansemert-Pago A., Vaucher P., Durieux-Paillard S., Bodenmann P., Cavassini M., 2018. pp. 163-172 dans Bodemann Patrick (eds.) Vulnérabilités, équité et santé chap. 2.4, RMS Editions.
 
Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Younus M., Mo J., Yan J., Ussetti P., Chin-Hong P.V., Solé A. et al., 2018/01. American journal of transplantation, 18 (1) pp. 113-124. Peer-reviewed.
 
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D., San-Juan R., Manuel O., Giménez E., Fernández-Ruiz M., Hirsch H.H., Grossi P.A., Aguado J.M., ESGICH CMV Survey Study Group on behalf of the European Study Group of Infections in Compromised Hosts (ESGICH) from the Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2017/12. Transplant infectious disease, 19 (6) p. 1. Peer-reviewed.
 
Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
Marzolini C., Decosterd L., Winterfeld U., Tissot F., Francini K., Buclin T., Livio F., 2017/12. British journal of clinical pharmacology, 83 (12) pp. 2835-2838. Peer-reviewed.
Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.
Perrotta G., Bonnier G., Meskaldji D.E., Romascano D., Aydarkhanov R., Daducci A., Simioni S., Cavassini M., Metral M., Lazeyras F. et al., 2017/12. Annals of clinical and translational neurology, 4 (12) pp. 915-920. Peer-reviewed.
 
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Robin C., Héquette-Ruz R., Guery B., Boyle E., Herbaux C., Galperine T., 2017/12. Medecine et maladies infectieuses, 47 (8) pp. 532-539. Peer-reviewed.
Low sensitivity of qSOFA, SIRS criteria and sepsis definition to identify infected patients at risk of complication in the prehospital setting and at the emergency department triage.
Tusgul S., Carron P.N., Yersin B., Calandra T., Dami F., 2017/11/03. Scandinavian journal of trauma, resuscitation and emergency medicine, 25 (1) p. 108. Peer-reviewed.
Self-diagnosis of malaria by travellers: a cohort study on the use of malaria rapid diagnostic tests provided by a Swiss travel clinic.
Berthod D., Rochat J., Voumard R., Rochat L., Genton B., D'Acremont V., 2017/10/28. Malaria journal, 16 (1) p. 436. Peer-reviewed.
Primary and Immortalized Human Respiratory Cells Display Different Patterns of Cytotoxicity and Cytokine Release upon Exposure to Deoxynivalenol, Nivalenol and Fusarenon-X.
Ferreira Lopes S., Vacher G., Ciarlo E., Savova-Bianchi D., Roger T., Niculita-Hirzel H., 2017/10/25. Toxins, 9 (11) pp. 337 [1-14]. Peer-reviewed.
 
A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
Keitel K., Kagoro F., Samaka J., Masimba J., Said Z., Temba H., Mlaganile T., Sangu W., Rambaud-Althaus C., Gervaix A. et al., 2017/10. PLoS medicine, 14 (10) pp. e1002411. Peer-reviewed.
 
A systematic review and meta-analysis of HCV clearance.
Gauthiez E., Habfast-Robertson I., Rüeger S., Kutalik Z., Aubert V., Berg T., Cerny A., Gorgievski M., George J., Heim M.H. et al., 2017/10. Liver international, 37 (10) pp. 1431-1445. Peer-reviewed.
 
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C., Wilk S., Achermann R., Binet I., Golshayan D., Hadaya K., Hirzel C., Hoffmann M., Huynh-Do U., Koller M.T. et al., 2017/10. American journal of transplantation, 17 (10) pp. 2591-2600. Peer-reviewed.
 
Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study.
Agyeman PKA, Schlapbach L.J., Giannoni E., Stocker M., Posfay-Barbe K.M., Heininger U., Schindler M., Korten I., Konetzny G., Niederer-Loher A. et al., 2017/10. The Lancet. Child & adolescent health, 1 (2) pp. 124-133. Peer-reviewed.
 
Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
Marzel A., Shilaih M., Turk T., Campbell N.K., Yang W.L., Böni J., Yerly S., Klimkait T., Aubert V., Furrer H. et al., 2017/10. HIV medicine, 18 (9) pp. 667-676. Peer-reviewed.
 
Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection.
Fischer J., Weber ANR, Böhm S., Dickhöfer S., El Maadidi S., Deichsel D., Knop V., Klinker H., Möller B., Rasenack J. et al., 2017/10. Gut, 66 (10) pp. 1829-1837. Peer-reviewed.
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Trickey A., May M.T., Schommers P., Tate J., Ingle S.M., Guest J.L., Gill M.J., Zangerle R., Saag M., Reiss P. et al., 2017/09/15. Clinical infectious diseases, 65 (6) pp. 959-966. Peer-reviewed.
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
Turk T., Bachmann N., Kadelka C., Böni J., Yerly S., Aubert V., Klimkait T., Battegay M., Bernasconi E., Calmy A. et al., 2017/09/12. eLife, 6 p. 1. Peer-reviewed.
 
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.
Oussalah A., Avogbe P.H., Guyot E., Chery C., Guéant-Rodriguez R.M., Ganne-Carrié N., Cobat A., Moradpour D., Nalpas B., Negro F. et al., 2017/09/08. Oncotarget, 8 (38) pp. 62842-62857. Peer-reviewed.
Adequate plasma drug concentrations suggest that amoxicillin can be administered by continuous infusion using elastomeric pumps.
Arensdorff L., Boillat-Blanco N., Decosterd L., Buclin T., de Vallière S., 2017/09/01. The Journal of antimicrobial chemotherapy, 72 (9) pp. 2613-2615. Peer-reviewed.
 
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.
Gebreselassie H.M., Kraus D., Fux C.A., Haubitz S., Scherrer A., Hatz C., Veit O., Stoeckle M., Fehr J., de Lucia S. et al., 2017/09. HIV medicine, 18 (8) pp. 564-572. Peer-reviewed.
 
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Bassetti M., Garnacho-Montero J., Calandra T., Kullberg B., Dimopoulos G., Azoulay E., Chakrabarti A., Kett D., Leon C., Ostrosky-Zeichner L. et al., 2017/09. Intensive care medicine, 43 (9) pp. 1225-1238. Peer-reviewed.
 
Malaria prevention strategies and recommendations, from chemoprophylaxis to stand-by emergency treatment: a 10-year prospective study in a Swiss Travel Clinic.
Boubaker R., Hérard Fossati A., Meige P., Mialet C., Ngarambe Buffat C., Rochat J., Souvannaraj-Blanchant M., Uwanyiligira M., Widmer F., Payot S. et al., 2017/09/01. Journal of travel medicine, 24 (5) pp. 1-9. Peer-reviewed.
 
Standby emergency treatment of malaria in travellers (SBET): So Be Eager to Test ….
Genton B., D'Acremont V., 2017/09/01. Journal of travel medicine, 24 (5) pp. 1-2. Peer-reviewed.
Adverse events of raltegravir and dolutegravir.
Elzi L., Erb S., Furrer H., Cavassini M., Calmy A., Vernazza P., Günthard H., Bernasconi E., Battegay M., Swiss HIV Cohort Study Group, 2017/08/24. AIDS, 31 (13) pp. 1853-1858. Peer-reviewed.
 
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
Blaser N., Bertisch B., Kouyos R.D., Calmy A., Bucher H.C., Cavassini M., Estill J., Keiser O., Egger M., Swiss HIV Cohort Study, 2017/08/24. AIDS, 31 (13) pp. 1859-1866. Peer-reviewed.
Clinical and laboratory predictors of death in African children with features of severe malaria: a systematic review and meta-analysis.
Sypniewska P., Duda J.F., Locatelli I., Althaus C.R., Althaus F., Genton B., 2017/08/03. BMC medicine, 15 (1) p. 147. Peer-reviewed.
 
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.
Pichenot M., Héquette-Ruz R., Le Guern R., Grandbastien B., Charlet C., Wallet F., Schiettecatte S., Loeuillet F., Guery B., Galperine T., 2017/08. Infection, 45 (4) pp. 425-431. Peer-reviewed.
 
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study.
Schäfer J., Young J., Calmy A., Nicca D., Hasse B., Brun Del Re C., Cavassini M., Bernasconi E., Schmidt-Trucksäss A., Bucher H.C. et al., 2017/08. AIDS care, 29 (8) pp. 1056-1061. Peer-reviewed.
Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps.
Saillen L., Arensdorff L., Moulin E., Voumard R., Cochet C., Boillat-Blanco N., Gardiol C., de Vallière S., 2017/08. European journal of clinical microbiology & infectious diseases, 36 (8) pp. 1387-1392. Peer-reviewed.
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
Antiretroviral Therapy Cohort Collaboration, 2017/08. The lancet. HIV, 4 (8) pp. e349-e356. Peer-reviewed.
 
The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.
Grandjean T., Boucher A., Thepaut M., Monlezun L., Guery B., Faudry E., Kipnis E., Dessein R., 2017/08/01. International immunology, 29 (8) pp. 377-384. Peer-reviewed.
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia.
Huttner A., Albrich W.C., Bochud P.Y., Gayet-Ageron A., Rossel A., Dach E.V., Harbarth S., Kaiser L., 2017/07/13. BMJ open, 7 (7) pp. e017996. Peer-reviewed.
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study.
Sculier D., Gayet-Ageron A., Battegay M., Cavassini M., Fehr J., Hirzel C., Schmid P., Bernasconi E., Calmy A., Swiss HIV Cohort Study, 2017/07/06. BMC infectious diseases, 17 (1) p. 476. Peer-reviewed.
An unusual case of miliary PML-IRIS in an HIV+ patient.
Cuendet D., Sarro R., Merz L., Jiménez M.C., Maeder P., Du Pasquier R., Tsouni P., 2017/07. Neurology(R) neuroimmunology & neuroinflammation, 4 (4) pp. e370. Peer-reviewed.
 
Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections.
Tagini F., Aubert B., Troillet N., Pillonel T., Praz G., Crisinel P.A., Prod'hom G., Asner S., Greub G., 2017/07. European journal of clinical microbiology & infectious diseases, 36 (7) pp. 1173-1180. Peer-reviewed.
 
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
Sirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections.
Ciarlo E., Heinonen T., Lugrin J., Acha-Orbea H., Le Roy D., Auwerx J., Roger T., 2017/06/20. Scientific reports, 7 (1) p. 3853. Peer-reviewed.
 
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Damonti L., Erard V., Garbino J., Schrenzel J., Zimmerli S., Mühlethaler K., Imhof A., Zbinden R., Fehr J., Boggian K. et al., 2017/06. Intensive care medicine, 43 (6) pp. 935-939. Peer-reviewed.
 
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
Lamoth F., Chung S.J., Damonti L., Alexander B.D., 2017/06/01. Clinical infectious diseases, 64 (11) pp. 1619-1621. Peer-reviewed.
 
Artemether-Lumefantrine Treatment Failure in Nonimmune European Travelers With Plasmodium falciparum Malaria: Do We Need to Reconsider Dosing in Patients From Nonendemic Regions?
Neumayr A., Paris D.H., Genton B., Hatz C., 2017/05/15. Clinical infectious diseases, 64 (10) pp. 1466-1467. Peer-reviewed.
Bactéries multirésistantes et voyage [Multidrug-resistant bacteria and travel]
De Vallière S., 2017/05/03. Revue medicale suisse, 13 (561) pp. 944-947. Peer-reviewed.
 
Panels gastro-intestinaux par PCR multiplex pour la prise en chargedes diarrhées du voyageur : performants et utiles ? [Multiplex PCR gastro-intestinal panels for the management of traveller's diarrhea : are they accurate and useful?]
Rochat L., Croxatto A., De Vallière S., D'Acremont V., Genton B., 2017/05/03. Revue medicale suisse, 13 (561) pp. 963-967. Peer-reviewed.
 
Prévenir et gérer les problèmes médicaux en navigation [To prevent and deal with medical problems on board]
Genton B., D'Acremont V., 2017/05/03. Revue medicale suisse, 13 (561) pp. 934-937. Peer-reviewed.
Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).
Voumard R., Van Neyghem N., Cochet C., Gardiol C., Decosterd L., Buclin T., de Valliere S., 2017/05/01. The Journal of antimicrobial chemotherapy, 72 (5) pp. 1462-1465. Peer-reviewed.
 
Fecal Microbiota Transplantation: Do We Need Harmonization?
Galpérine T., Sokol H., Guery B., 2017/05/01. Clinical infectious diseases, 64 (9) p. 1292. Peer-reviewed.
First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.
Dellicour S., Sevene E., McGready R., Tinto H., Mosha D., Manyando C., Rulisa S., Desai M., Ouma P., Oneko M. et al., 2017/05. PLoS medicine, 14 (5) pp. e1002290. Peer-reviewed.
 
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.
Béguelin C., Friolet N., Moradpour D., Sahli R., Suter-Riniker F., Lüthi A., Cavassini M., Günthard H.F., Battegay M., Bernasconi E. et al., 2017/05/01. Clinical infectious diseases, 64 (9) pp. 1275-1278. Peer-reviewed.
 
Universal screening and decolonization for control of MRSA in nursing homes: follow-up of a cluster randomized controlled trial.
Héquet D., Rousson V., Blanc D.S., Büla C., Qalla-Widmer L., Masserey E., Zanetti G., Petignat C., 2017/05. The Journal of hospital infection, 96 (1) pp. 69-71. Peer-reviewed.
 
Evaluation de la plateforme Neuro-VIH d’un hôpital universitaire par les patients et les médecins traitants [Evaluation of an outpatient multidisciplinary Neuro-HIV clinic by the patients and referring doctors]
Vallotton K., Métral M., Chocron O., Meuli R., Alves D., Du Pasquier R., Cavassini M., 2017/04/12. Revue medicale suisse, 13 (558) pp. 782-786. Peer-reviewed.
 
Evaluation des difficultés psychosociales des personnes VIH au sein d’une consultation infirmière [Evaluation of psychosocial difficulties and needs of persons living with HIV in a nurse consultation]
Courvoisier C., Manuel I.C., Gentizon J., Niklas-Lyon V., Tissot F., 2017/04/12. Revue medicale suisse, 13 (558) pp. 787-791. Peer-reviewed.
 
Guidelines : fausse route ou voie dorée ?
Huttner B., Cavassini M., 2017/04/12. Revue medicale suisse, 13 (558) pp. 779-780. Peer-reviewed.
 
Toxocarose : une maladie négligée en Suisse ? [Toxocariasis, a neglected disease in Switzerland ?]
Duréault A., Perez Valdes C., Weber L., Ogna A., Sempoux C., Manuel O., Delaloye J., 2017/04/12. Revue medicale suisse, 13 (558) pp. 815-819. Peer-reviewed.
 
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.
Aouri M., Barcelo C., Guidi M., Rotger M., Cavassini M., Hizrel C., Buclin T., Decosterd L.A., Csajka C., Swiss HIV Cohort Study, 2017/04. Antimicrobial agents and chemotherapy, 61 (1) p. 10. Peer-reviewed.
 
Early diagnosis of invasive mould infections and disease.
Lamoth F., Calandra T., 2017/03/01. The Journal of antimicrobial chemotherapy, 72 (suppl_1) pp. i19-i28. Peer-reviewed.
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
Tissot F., Agrawal S., Pagano L., Petrikkos G., Groll A.H., Skiada A., Lass-Flörl C., Calandra T., Viscoli C., Herbrecht R., 2017/03. Haematologica, 102 (3) pp. 433-444. Peer-reviewed.
 
Proposal for shorter antibiotic therapies.
Wintenberger C., Guery B., Bonnet E., Castan B., Cohen R., Diamantis S., Lesprit P., Maulin L., Péan Y., Peju E. et al., 2017/03. Medecine et maladies infectieuses, 47 (2) pp. 92-141. Peer-reviewed.
 
Human papillomavirus antibody response following HAART initiation among MSM.
Combes J.D., Clifford G.M., Egger M., Cavassini M., Hirsch H.H., Hauser C., Calmy A., Schmid P., Bernasconi E., Günthard H.F. et al., 2017/02/20. AIDS, 31 (4) pp. 561-569. Peer-reviewed.
 
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
Kovari H., Rauch A., Kouyos R., Rougemont M., Cavassini M., Schmid P., Stöckle M., Bernasconi E., Weber R., Ledergerber B. et al., 2017/02/15. Clinical infectious diseases, 64 (4) pp. 490-497. Peer-reviewed.
 
Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.
Han S.H., Kumar D., Ferreira V.H., Egli A., Hirsch H.H., Weisser M., Garzoni C., van Delden C., Bochud P.Y., Manuel O. et al., 2017/02/15. The Journal of infectious diseases, 215 (4) pp. 537-546. Peer-reviewed.
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
Gueler A., Moser A., Calmy A., Günthard H.F., Bernasconi E., Furrer H., Fux C.A., Battegay M., Cavassini M., Vernazza P. et al., 2017/01/28. AIDS, 31 (3) pp. 427-436. Peer-reviewed.
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Beaume M., Köhler T., Greub G., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Buckling A., van Delden C., Swiss Transplant Cohort Study, 2017/01/17. Scientific reports, 7 p. 40309. Peer-reviewed.
 
Performance of Health Workers Using an Electronic Algorithm for the Management of Childhood Illness in Tanzania: A Pilot Implementation Study.
Rambaud-Althaus C., Shao A., Samaka J., Swai N., Perri S., Kahama-Maro J., Mitchell M., D'Acremont V., Genton B., 2017/01/11. The American journal of tropical medicine and hygiene, 96 (1) pp. 249-257. Peer-reviewed.
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research Initiative.
Neumayr A., Muñoz J., Schunk M., Bottieau E., Cramer J., Calleri G., López-Vélez R., Angheben A., Zoller T., Visser L. et al., 2017/01/05. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 22 (1) pp. 39-47. Peer-reviewed.
Bacillus cereus bacteraemia: comparison between haematologic and nonhaematologic patients.
Tusgul S., Prod'hom G., Senn L., Meuli R., Bochud P.Y., Giulieri S.G., 2017/01. New microbes and new infections, 15 pp. 65-71. Peer-reviewed.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University